[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2020.04.019.0118Pharm Sci Asia 2020; 47(4), 387-398
 

Hospital-acquired pneumonia in an intensive care unit in Vietnam: clinical characteristics and pathogenic bacteria

Thao T.B. Nguyen1, Kien T. Nguyen2, Suol T. Pham3*, Xuan D. Pham4, Thang Nguyen3

1 Department of Intensive Care, Can Tho General Hospital, Can Tho, Vietnam
2 Department of Physiology, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam
3 Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam
4 Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam


The increase in the number of multi-drug resistant bacteria causing nosocomial infections at the hospital’s intensive care unit (ICU) is a major worldwide problem. This leads to the need for research on clinical characteristics and pathogenic bacteria of hospital-acquired pneumonia (HAP) patients. Our research aimed to describe the clinical characteristics and identify the patterns of causative agents in HAP patients. We conducted a cross-sectional descriptive study on 103 HAP patients treated in ICU of a major hospital in Can Tho City, Vietnam from May 2017 to May 2018. The identification and antimicrobial susceptibility of cultures were determined using an automated microbiology analyzer; the Bauer–Kirby disk diffusion method was used. Of 103 patients met the inclusion criteria, 95 patients were confirmed as presenting with HAP caused by MDR bacteria. The overall prevalence was higher in men than in women and increased with age. There was some evidence of a correlation between prior broad-spectrum antibiotic use and the incidence of HAP. The sputum color change and hyperthermia were common clinical symptoms in HAP diagnosing. Notably, the proportion of multiple-antibiotic-resistant bacteria causing HAP was 92.5%. High rates of most common antibiotic resistance were observed in Acinetobacter baumannii, Klebsiella, Pseudomonas aeruginosa and also E. coli. The success rate of treatment for HAP caused by MDR bacteria accounted for 49.5%. The resistance rates of Acinetobacter baumannii and Pseudomonas aeruginosa to most common antibiotics were increasing substantially. The initial treatment for HAP ought to comply with combined antibiotic therapy or a new treatment strategy.


Keyword:

Hospital-acquired pneumonia (HAP); Ventilator-associated pneumonia (VAP); Intensive Care Unit (ICU); Clinical characteristics; Pathogenic bacteria




Download full paper (PDF File size: 481.70 KB.)





Vol.47
No.4
October - December 2020

See other volume

 


Vol.47
No.3
July - September 2020

See other volume

 


Vol.47
No.2
April - June 2020

See other volume

 


Vol.47
No.1
January - March 2020

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2024
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.